Drug Shortage Report for MINT-RISPERIDON
| Report ID | 122513 |
| Drug Identification Number | 02359839 |
| Brand name | MINT-RISPERIDON |
| Common or Proper name | Risperidon |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RISPERIDONE |
| Strength(s) | 3.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 count bottles |
| ATC code | N05AX |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-08-19 |
| Estimated end date | 2020-09-18 |
| Actual end date | 2020-09-18 |
| Shortage status | Resolved |
| Updated date | 2020-09-21 |
| Company comments | In Transit delay due to strike. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-09-21 | French | Compare |
| v6 | 2020-09-21 | English | Compare |
| v5 | 2020-08-20 | English | Compare |
| v4 | 2020-08-19 | French | Compare |
| v3 | 2020-08-19 | English | Compare |
| v2 | 2020-08-19 | French | Compare |
| v1 | 2020-08-19 | English | Compare |
Showing 1 to 7 of 7